FDA puts highest-risk category on Symbios infusion pump recall

March 19, 2013 by Arezu Sarvestani

The FDA assigned Symbios Medical Products' infusion pump recall Class I status over concerns that a displaced restrictor bead could results in overdose.

Symbios Logo

Symbios Medical Products recalled certain lots of its GOPump Elastomeric Infusion PumpKit systems over concerns that a component that moderates the flow of medicine from the pump may fail and cause an overdose.

The FDA placed Class I status on the recall, a category reserved for issues which "may cause serious adverse health consequences, including death," according to an agency notice.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp